Developments in 5-Hydroxytriptamine Receptor Pharmacology in Migraine

This publication has 49 references indexed in Scilit:

• 5-HT1-like receptor agonists and the pathophysiology of migraine
  Trends in Pharmacological Sciences, 1989
• Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain
  Trends in Pharmacological Sciences, 1989
• Nifedipine Versus Propranolol for the Initial Prophylaxis of Migraine
  Headache: The Journal of Head and Face Pain, 1989
• 5-Hydroxytryptamine Receptor Subtypes
  Annual Review of Neuroscience, 1988
• FIRST RESULTS WITH ICS 205-930 (5-HT3 RECEPTOR ANTAGONIST) IN PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS
  The Lancet, 1987
• Antimigraine drug interactions with 5‐hydroxytryptamine_1A receptors
  Annals of Neurology, 1986
• Brain Hypoxia: The Turning-Point in the Genesis of the Migraine Attack?
  Cephalalgia, 1982
• Comparative Trial of Tenormin (Atenolol) and Inderal (Propranolol) in Migraine
  Headache: The Journal of Head and Face Pain, 1980
• CLINICAL TRIAL OF A BETA-RECEPTOR BLOCKING AGENT (LB 46) IN MIGRAINE PROPHYLAXIS
  Acta Neurologica Scandinavica, 1972
• Historical Development of the Ergot Therapy of Migraine
  International Archives of Allergy and Immunology, 1955